| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/06/2006 | US20060075518 Polypeptides having lipase activity and polynucleotides encoding same |
| 04/06/2006 | US20060075510 Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor |
| 04/06/2006 | US20060074234 Isolated mammalian membrane protein genes; related reagents |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074228 antibody specifically binds to a polypeptide used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |
| 04/06/2006 | US20060074227 Antibodies against PRO Polypeptides which may be overexpressed in tumors |
| 04/06/2006 | US20060074226 Pro9835 antibodies |
| 04/06/2006 | US20060074224 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060074221 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060074044 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 04/06/2006 | US20060074037 Producing/evaluating a protein/polypeptide (alpha-defensin) with increased antimicrobial activity and stability to effect chemotaxis of T-cells, neutrophil recruitment, or cytokine or interleukin-8 release; immunostimulants; respiratory system disorders; inflammatory bowel disease; viricides; cancer; HIV |
| 04/06/2006 | US20060074033 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060074023 Angiogenesis associated proteins, and nucleic acids encoding the same |
| 04/06/2006 | US20060074008 monoclonal antibody conjugated with peptide drug such as dolastatin derivative |
| 04/06/2006 | US20060073591 Cell culture media |
| 04/06/2006 | US20060073586 A N-terminal domain, five or six rod repeats, H1 and H4 domains of a dystrophin protein, and a cysteine-rich domain; Duchenne and Becker muscular dystrophies |
| 04/06/2006 | US20060073583 food additive with a PS4 variant polypeptide derivable from a parent polypeptide having non-maltogenic exoamylase activity; baked goods; glucan 1,4-alpha-maltotetrahydrolase activity |
| 04/06/2006 | US20060073580 Glucose dehydrogenase |
| 04/06/2006 | US20060073576 envelope proteins (Env) comprising CD4 (and mimetics) binding site and deletion region; maintains structural conformation of complementary determining region 2-like loop; insertion near chemokine receptor binding site; vectors, cells; liposomes |
| 04/06/2006 | US20060073574 Engineered biosynthesis of novel polyenes |
| 04/06/2006 | US20060073573 Chemotactic cytokine III |
| 04/06/2006 | US20060073572 Cytokine structurally related to IL-17 |
| 04/06/2006 | US20060073570 Apo-2 receptor |
| 04/06/2006 | US20060073569 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/06/2006 | US20060073568 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073566 Active modified hedgehog proteins |
| 04/06/2006 | US20060073565 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 04/06/2006 | US20060073564 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) |
| 04/06/2006 | US20060073563 Erythropoietin derivatives with altered immunogenicity |
| 04/06/2006 | US20060073562 Screening and identifying compounds compounds that will modulate the interaction of protein tyrosine kinase substrates with their intracellular ligands, as well as between their intracellular ligands and other members of the signaling pathway. |
| 04/06/2006 | US20060073561 157 human secreted proteins |
| 04/06/2006 | US20060073560 Selective expression in filamentous fungi |
| 04/06/2006 | US20060073559 Ehanced protein expression in bacillus |
| 04/06/2006 | US20060073558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073557 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073556 polypeptide that is an epitope tag or a Fc region of an immunoglobulin; used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |
| 04/06/2006 | US20060073555 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073554 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073553 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073552 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073551 Pro4487 polypeptides |
| 04/06/2006 | US20060073550 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073549 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073548 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073547 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073546 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073545 PRO polypeptides and chimeric polypeptides; may be drug target for tumors |
| 04/06/2006 | US20060073544 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073543 Process for the preparation of angiotensis converting enzyme (ACE) inhibitors and its use |
| 04/06/2006 | US20060073542 Catalyze transfer of a fucose residue from a donor to an acceptor substrate in enzymatic synthesis of oligosaccharide moieties of glycoproteins and glycolipids |
| 04/06/2006 | US20060073533 Production of ugppase |
| 04/06/2006 | US20060073517 Post-translational modifications of proteins as regulatory switches |
| 04/06/2006 | US20060073516 Novel screening method |
| 04/06/2006 | US20060073515 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same |
| 04/06/2006 | US20060073507 Orthogonal pairs of tRNAs and aminoacyl-tRNA synthetases incorporate para-propargyloxyphenylalanine into proteins produced in E. coli |
| 04/06/2006 | US20060073498 GlcNAc phosphotransferase of the lysosomal targeting pathway |
| 04/06/2006 | US20060073497 Isolated polypeptide from a macrophage, inflammatory cell, liver cell, hepatocyte, intestinal cell, hematopoietic cell, pancreatic cell, skeletal muscle cell, nervous system; modulation of iron transport across a cell membrane; regulate diseases of iron metabolism |
| 04/06/2006 | US20060073476 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/06/2006 | US20060073468 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof |
| 04/06/2006 | US20060073169 Acellular antibordetella vaccine |
| 04/06/2006 | US20060073168 contacting an isolated serogroup A meningococcal capsular polysaccharide with an isolated Serogroup A Neisseria meningitidis O-acetyltransferase polypeptide; immunogenic compositions; vaccine for generating a protective immune response to Neisseria meningitidis |
| 04/06/2006 | US20060073162 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 04/06/2006 | US20060073155 Methods and compositions for diseases associated with amyloidosis |
| 04/06/2006 | US20060073153 Individualized anti-cancer antibodies |
| 04/06/2006 | US20060073152 Therapeutic agents with decreased toxicity |
| 04/06/2006 | US20060073150 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 04/06/2006 | US20060073148 IL-13 binding agents |
| 04/06/2006 | US20060073147 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/06/2006 | US20060073146 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 04/06/2006 | US20060073145 Methods and compositions for inhibiting CD14 mediated cell activation |
| 04/06/2006 | US20060073144 Individualized anti-cancer antibodies |
| 04/06/2006 | US20060073139 Vaccine composition for preventing meningococcal disease |
| 04/06/2006 | US20060073138 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 04/06/2006 | US20060073137 Humanised antibodies |
| 04/06/2006 | US20060073136 Humanised antibodies |
| 04/06/2006 | US20060073133 Sialoadhesin factor-3 antibodies |
| 04/06/2006 | US20060073115 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis, inflamamatory disorders or infection by microorganisms |
| 04/06/2006 | US20060073095 Methods for screening antibody-producing cells on heterogeneous antigen substrates |
| 04/06/2006 | DE10240098B4 Verfahren zur Synthese und selektiven biokatalytischen Modifizierung von Peptiden, Peptidmimetika und Proteinen A process for the synthesis and selective biocatalytic modification of peptides, peptide mimetics and proteins |
| 04/06/2006 | CA2581469A1 Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same |
| 04/06/2006 | CA2581352A1 Methods for identifying new drug leads and new therapeutic uses for known drugs |
| 04/05/2006 | EP1642980A1 Modified proteins and methods of their production |
| 04/05/2006 | EP1642979A1 Fucosyltransferase gene |
| 04/05/2006 | EP1642975A2 Chemokine receptors 88-2B (CKR-3) and their antibodies |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642971A1 Fucose transporter |
| 04/05/2006 | EP1642968A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642967A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642909A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 04/05/2006 | EP1642908A2 Apoptosis-induced site from fas ligand |
| 04/05/2006 | EP1642907A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642906A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642904A1 Protein achieving improved blocking efficiency |
| 04/05/2006 | EP1642506A2 Use of acid-stable subtilisin proteases in animal feed |
| 04/05/2006 | EP1641422A2 Interleukin-21 analogs |
| 04/05/2006 | EP1126912B1 Kit for carrying out biochemical reactions with a high throughput |
| 04/05/2006 | EP1049718B1 Use of the antibody 271.14d9.f8 (dsm acc2331) to inhibit in vitro alphavbeta6-integrin attachment to fibronectin |
| 04/05/2006 | EP1049713B1 Antifreeze protein |